Bacterial Disease Diagnostics Market Size

  • Report ID: 5206
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Bacterial Disease Diagnostics Market size was valued at USD 3.49 billion in 2024 and is expected to reach USD 9.38 billion by 2037, registering around 7.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of bacterial disease diagnostics is assessed at USD 3.95 billion.

The growth of the market can be attributed to the growing incidences of mass food poisoning. In the world, around 600 million fell ill due to the consumption of contaminated food and nearly 33 million lost their lives. Bacterial illness is a leading cause of food poisoning in humans. As consumers become increasingly worried about food safety, the demand for trustworthy bacterial illness diagnostics grows.

In addition to this, one aspect that is expected to drive the growth of the bacterial disease diagnostics market is rising research on new treatments and diagnoses. BARDA has collaborated with the government to help a number of companies research novel infectious disease medications. Ongoing research aids in the identification and description of new bacterial pathogens. Researchers can aid in the development of diagnostic tests for these novel infections, aiding disease control.


Bacterial Disease Diagnostics Market overview

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of bacterial disease diagnostics is assessed at USD 3.95 billion.

The bacterial disease diagnostics market size was valued at USD 3.49 billion in 2024 and is expected to reach USD 9.38 billion by 2037, registering around 7.9% CAGR during the forecast period i.e., between 2025-2037. Increasing cases of bacterial infection and technological advancement in diagnostic technology will boost the market growth.

North America industry is predicted to dominate majority revenue share of 35% by 2037, due to rising instances of fatal infections caused by bacteria in the region.

The major players in the market are bioMérieux SA, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton, Dickinson and Company, DiaSorin SpA (Luminex), Accelerate Diagnostics Inc., Bruker Corp., Danaher Corp., Torus Biosystems, GENERI BIOTECH s.r.o.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos